The differential diagnosis of pancreatic carcinoma and tumor-forming pancreatitis remains diffi cult, and this situation can cause serious problems because the management and prognosis of these two focal pancreatic masses are entirely different. We herein report a case of tumor-forming pancreatitis that mimics pancreatic carcinoma in an 80-year-old woman. Computed tomography showed a solid mass in the head of the pancreas, and endoscopic retrograde cholangiopancreatography showed a complete obstruction of the main pancreatic duct in the head of the pancreas. Dynamic contrastenhanced magnetic resonance imaging (MRI) demonstrated a time-signal intensity curve (TIC) with a slow rise to a peak (1 min after the administration of the contrast material), followed by a slow decline at the pancreatic mass, indicating a fi brotic pancreas. Under the diagnosis of tumor-forming pancreatitis, the patient underwent a segmental pancreatectomy instead of a pancreaticoduodenectomy. The histopathology of the pancreatic mass was chronic pancreatitis without malignancy. The pancreatic TIC obtained from dynamiccontrast MRI can be helpful to differentiate tumor-forming pancreatitis from pancreatic carcinoma and to avoid any unnecessary major pancreatic surgery.
Introduction
Although various diagnostic modalities have been proposed to provide an accurate diagnosis, the differential diagnosis of pancreatic carcinoma and tumor-forming pancreatitis remains unsettled. [1] [2] [3] [4] [5] The differential diagnosis between pancreatic carcinoma and tumor-forming pancreatitis is exceedingly important because there is an extreme difference in the management and prognosis of these two pancreatic entities. We have previously reported that the time-signal intensity curve (TIC) of the pancreas obtained from dynamic contrast-enhanced magnetic resonance imaging (MRI) is a reliable indicator of pancreatic fi brosis. 6 In addition, pancreatic TIC from dynamic MRI provides dependable information for differentiating pancreatic carcinoma from tumorforming pancreatitis. 7 The patterns of pancreatic TIC were classifi ed into four types according to the time to a peak, as follows: 25 s and 1, 2, and 3 min after the bolus injection of the contrast material, namely, type I, II, III, and IV, respectively. 6 We herein report the utility of the preoperative pancreatic TIC from dynamic MRI in the diagnosis of tumor-forming pancreatitis that mimics pancreatic carcinoma.
Case Report
An 80-year-old woman was referred to our department for further evaluation of an asymptomatic pancreatic mass that was found accidentally on ultrasonography during a routine health examination at a private clinic. On admission she had no complaints, and no abnormalities were found on a physical examination. She had no history of alcohol consumption. The preoperative blood examinations were within the normal limits, except for elevated carbohydrate antigen 19-9 levels of 101 IU/ml (normal range, 0-37 IU/ml), DUPAN-2 levels of 560 IU/ ml (normal range, 0-150 IU/ml), serum IgG levels of 1850 mg/dl (normal range, 870-1700 mg/dl), and IgG4 levels of 198 mg/dl (normal range, 4.8-105 mg/dl). Her carcinoembryonic antigen levels were within normal limits. Computed tomography (CT) revealed a solid mental pancreatectomy instead of receiving a pancreaticoduodenectomy. A histopathologic examination of the resected pancreatic mass showed pronounced infl ammatory cell infi ltration around the main pancreatic duct. The patient's postoperative course was uneventful. She was discharged on the 12th postoperative day.
Discussion
The preoperative differentiation of tumor-forming pancreatitis and pancreatic carcinoma is diffi cult because the imaging fi ndings of these masses are very similar. [1] [2] [3] [4] [5] Recently, various diagnostic techniques have been proposed for the accurate differential diagnosis of pancreatic masses. Endoscopic ultrasound (EUS)-guided fi ne-needle aspiration biopsy is reportedly useful in ren- (1) and the nontumorous pancreatic parenchyma proximal to the mass lesion (2) mass in the head of the pancreas, 3.0 cm in diameter, which showed a progressive enhancement from the arterial phase to the portal venous phase and a slight enhancement in the delayed phase on contrast-enhanced CT scans (Fig. 1) . Endoscopic retrograde cholangiopancreatography (ERCP) showed a complete obstruction of the main pancreatic duct in the head of the pancreas (Fig. 2 ). There were no malignant cells in the pancreatic juice collected by endoscopic cannulation and brushing cytology. Dynamic contrast-enhanced MRI demonstrated a TIC profi le with a slow rise to a peak (1 min after the administration of the contrast material), followed by a slow decline (type II) at the pancreatic mass in the head of the pancreas (Fig. 3) . The pancreatic parenchyma distal to the mass lesion also showed a type II TIC. At the nontumorous pancreatic parenchyma proximal to the mass lesion, dynamic contrast-enhanced MRI showed a TIC profi le with a rapid rise to a peak (25 s after the injection of the contrast material), followed by a rapid decline (type I). Therefore, we diagnosed the pancreatic mass as being tumor-forming pancreatitis. We explained these fi ndings and its implications to this patient and obtained the patient's consent. The patient underwent a surgical resection with a seg-dering a differential diagnosis for a pancreatic mass, including tumor-forming pancreatitis and pancreatic carcinoma. 8 Okai et al. 9 reported that EUS combined with ERCP is useful for the differentiation of tumorforming pancreatitis from malignant tumors, for early diagnosis, and for monitoring the therapeutic effects. In contrast, Ohtsubo et al. 10 reported that hypermethylation analyses of the cancer-specifi c genes in the pure pancreatic juice supports a differential diagnosis. However, these diagnostic modalities are both relatively invasive.
Our previous study of the differentiation of the focal pancreatic masses with dynamic contrast-enhanced MRI demonstrated that a TIC profi le analysis is useful for the diagnosis of the pancreatic masses. 7 The patterns of pancreatic TIC were classifi ed into four types. The normal pancreas shows the type I TIC. In the previous study, pancreatic carcinomas demonstrated type III or type IV TIC, and the type IV TIC was only recognized in pancreatic carcinoma. 7 Meanwhile, tumor-forming pancreatitis showed type II or type III. The type III TIC showed an overlap in the TIC profi le between pancreatic carcinoma and tumor-forming pancreatitis. In contrast, the type II TIC exhibited a unique profi le indicative of chronic pancreatitis, including tumor-forming pancreatitis. In the present case, the focal mass lesion demonstrated a type II TIC. Therefore, we diagnosed the mass as tumor-forming pancreatitis, and performed a segmental pancreatectomy as a total biopsy of the mass lesion.
In conclusion, the pancreatic TIC profi le from dynamic MRI may help to differentiate tumor-forming pancreatitis from pancreatic carcinoma. This imaging technique is a less invasive diagnostic tool than other diagnostic modalities and it therefore enables us to eliminate an overdiagnosis and/or unnecessary major pancreatic surgery.
